Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0005) is a clinical research site located in Lancaster, Pennsylvania, United States 17601.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0005) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Small Cell Lung Carcinoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0005) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0005) has 1 clinical trials on record, with 1 currently active. Their work covers Small Cell Lung Carcinoma.
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0005) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.